Literature DB >> 7333899

T4NOMO glottic cancer: an analysis of dose-time volume factors.

A R Harwood, F A Beale, B J Cummings, T J Keane, D Payne, W D Rider.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7333899     DOI: 10.1016/0360-3016(81)90079-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  6 in total

1.  [Reasons for the terms "radiosurgery" and "Gamma Knife"].

Authors:  K Hamm; G Surber
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

2.  High-dose radiotherapy alone for patients with T4-stage laryngeal cancer.

Authors:  A Mucha-Małecka; K Składowski
Journal:  Strahlenther Onkol       Date:  2013-07-05       Impact factor: 3.621

3.  Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  James Bonner; Jordi Giralt; Paul Harari; Sharon Spencer; Jeltje Schulten; Anwar Hossain; Shao-Chun Chang; Steve Chin; José Baselga
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-09-01       Impact factor: 6.223

4.  Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment.

Authors:  Ming-Hung Hu; Ling-Wei Wang; Hsueh-Ju Lu; Pen-Yuan Chu; Shyh-Kuan Tai; Tsung-Lun Lee; Ming-Huang Chen; Muh-Hwa Yang; Peter Mu-Hsin Chang
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

5.  Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Shigeru Hirano; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2018-01-01       Impact factor: 2.724

Review 6.  Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.